Delivery Order SPE2DB22D2005-SPE2DB25FJHK6
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The $61,311.65 firm-fixed-price contract has an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to support various federal healthcare programs and military treatment facilities through its extensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,314.47 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, which was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,256.76, is a Delivery Order contract with a Firm Fixed Price pricing type. The contracting agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisitions, and technical services to the U.S. Armed Forces. This...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, procured by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,111.80 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024 with a completion date of August 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, with a ceiling value of $34,846.54. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which serves as...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,633.87 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 5, 2024 with a completion date of August 6, 2024. The contract is not designated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $61,796.23 and an ultimate completion date of February 29, 2024. The contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $90,448.07 for the procurement of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract, which has an ultimate completion date of November 21, 2023, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,568.98 firm fixed-price delivery order contract runs until January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,974.55, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through March 5, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...